Isoxazolone based inhibitors of p38 MAP kinases

被引：36

作者：

Laufer, Stefan A. ^{[1
]}

Margutti, Simona ^{[1
]}

机构：

[1] Univ Tubingen, Dept Pharmaceut & Med Chem, Inst Pharm, D-72076 Tubingen, Germany

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2008年 / 51卷 / 08期

关键词：

D O I：

10.1021/jm701343f

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

SAR of N-alkylated isoxazolones as p38 MAP kinase inhibitors was realized. The data herein show the possibility of transferring the SAR study and evaluation from N-1-substituted imidazole to isoxazolones. Optimization of substituent was realized.

引用

页码：2580 / 2584

页数：5

共 50 条

[41] Role of p38 MAP kinases in oncogene-induced malignant transformation
Nebreda, A.
Dolado, I.
Cuadrado, A.
Lafarga, V.
Swat, A.
FEBS JOURNAL, 2006, 273 : 58 - 58
[42] The design and synthesis of novel α-ketoamide-based p38 MAP kinase inhibitors
Montalban, Antonio Garrido
Boman, Erik
Chang, Chau-Dung
Ceide, Susana Conde
Dahl, Russell
Dalesandro, David
Delaet, Nancy G. J.
Erb, Eric
Ernst, Justin T.
Gibbs, Andrew
Kahl, Jeffrey
Kessler, Linda
Lundstroem, Jan
Miller, Stephen
Nakanishi, Hiroshi
Roberts, Edward
Saiah, Eddine
Sullivan, Robert
Wang, Zhijun
Larson, Christopher J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (06) : 1772 - 1777
[43] The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
Liao, P
Georgakopoulos, D
Kovacs, A
Zheng, MZ
Lerner, D
Pu, HY
Saffitz, J
Chien, K
Xiao, RP
Kass, DA
Wang, YB
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (21) : 12283 - 12288
[44] Pyridazine based inhibitors of p38 MAPK
McIntyre, CJ
Ponticello, GS
Liverton, NJ
O'Keefe, SJ
O'Neill, EA
Pang, M
Schwartz, CD
Claremon, DA
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (04) : 689 - 692
[45] Pharmacophore modeling of diverse classes of p38 MAP kinase inhibitors
Sarma, Rituparna
Sinha, Sharat
Ravikumar, Muttineni
Kumar, Madala Kishore
Mahmood, S. K.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (12) : 2870 - 2876
[46] Process Research and Development for Heterocyclic p38 MAP Kinase Inhibitors
Thiel, Oliver R.
Achmatowicz, Michal
Milburn, Robert M.
SYNLETT, 2012, (11) : 1564 - 1574
[47] Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase
Tamayo, N
Liao, L
Goldberg, M
Powers, D
Tudor, YY
Yu, V
Wong, LM
Henkle, B
Middleton, S
Syed, R
Harvey, T
Jang, G
Hungate, R
Dominguez, C
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) : 2409 - 2413
[48] Allosteric and slow binding inhibitors of p38 MAP kinase.
Regan, J
Breitfelder, S
Cirillo, P
Gilmore, T
Graham, A
Hickey, E
Madwed, J
Moriak, M
Moss, N
Pargellis, C
Proto, A
Tong, L
Torcellini, C
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U683 - U683
[49] The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase
Wilson, KP
McCaffrey, PG
Hsiao, K
Pazhanisamy, S
Galullo, V
Bemis, GW
Fitzgibbon, MJ
Garon, PR
Murcko, MA
Su, MSS
CHEMISTRY & BIOLOGY, 1997, 4 (06): : 423 - 431
[50] p38 MAP kinase inhibitors: Many are made, but few are chosen
Dominguez, C
Powers, DA
Tamayo, N
CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2005, 8 (04) : 421 - 430

← 1 2 3 4 5 →